Carboplatin, Paclitaxel, and Temozolomide for Patients With Metastatic Melanoma

Summary

The number of melanoma cases has been steadily increasing over the past few decades. For many patients with metastatic melanoma, there are no effective therapies. The goal of this study is to determine whether a combination drug treatment of carboplatin, paclitaxel and temozolomide is effective in the treatment of metastatic or recurrent melanoma.

Timeline

Start

2009-08

Primary completion

2013-09

Completion

2015-06

Outcome

Outcome not reported

Stopped (Enrollment): “Low accrual; target accrual not met”

Drugs

Indications